Evidence map›Paper›PMID 30339041›Full record

ArticleRNA biology2018

RNA accessibility impacts potency of Tough Decoy microRNA inhibitors.

Marjolein J G Hooykaas, Jasper A Soppe, Hendrik M De Buhr, Elisabeth Kruse, Emmanuel J H J Wiertz, Robert J Lebbink

Open access · hybridAbstract read
In one paragraph

Article in RNA biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Are RNA Therapies a Solid Foundation or a Frontier Yet to Be Conquered?International journal of molecular sciences · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Let-7 underlies metformin-induced inhibition of hepatic glucose production.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Marjolein J G Hooykaasa Department of Medical Microbiology , University Medical Center Utrecht , Utrecht , The Netherlands.
Jasper A Soppea Department of Medical Microbiology , University Medical Center Utrecht , Utrecht , The Netherlands.
Hendrik M De Buhra Department of Medical Microbiology , University Medical Center Utrecht , Utrecht , The Netherlands.
Elisabeth Krusea Department of Medical Microbiology , University Medical Center Utrecht , Utrecht , The Netherlands.
Emmanuel J H J Wiertza Department of Medical Microbiology , University Medical Center Utrecht , Utrecht , The Netherlands.
Robert J Lebbinka Department of Medical Microbiology , University Medical Center Utrecht , Utrecht , The Netherlands.ORCID 0000-0002-1981-0420
University Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) are small RNA molecules that post-transcriptionally regulate gene expression through silencing of complementary target mRNAs. miRNAs are involved in many biological processes, including cell proliferation, differentiation, cell signaling and cellular defense responses to infection. Strategies that allow for strong and stable suppression of specific microRNA activity are needed to study miRNA functions and to develop therapeutic intervention strategies aimed at interfering with miRNA activity in vivo. One of these classes of miRNA inhibitors are Tough Decoys (TuD) RNAs, which comprise of an imperfect RNA hairpin structure that harbors two opposing miRNA binding sites. Upon developing TuDs targeting Epstein-Barr virus miRNAs, we observed a strong variation in inhibitory potential between different TuD RNAs targeting the same miRNA. We show that the composition of the 'bulge' sequence in the miRNA binding sites has a strong impact on the inhibitory potency of the TuD. Our data implies that miRNA inhibition correlates with the thermodynamic properties of the TuD and that design aimed at lowering the TuD opening energy increases TuD potency. Our study provides specific guidelines for the design and construction of potent decoy-based miRNA inhibitors, which may be used for future therapeutic intervention strategies.

Indexed as

Nucleic Acid ConformationBinding SitesHerpesvirus 4, HumanHumansMicroRNAsRNARNA, Small InterferingThermodynamicsMicroRNAsRNARNA, Small InterferingEBVMicrornamicroRNA inhibitorOpening energyRNA accessibilityTough Decoy

Identifiers

PMID30339041
PMCPMC6284568
OpenAlexW2897092007

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.